Ghana strengthens health system for new HIV prevention tools
Ghana is integrating new HIV prevention technologies, such as long-acting injectable medicines, into its primary healthcare system. The National AIDS Control Programme aims to improve service efficiency and sustainability amidst declining international funding.
Why it matters
This strategy highlights how developing nations are adapting their public health infrastructure to manage chronic diseases independently as global donor priorities shift.
Rio de Janeiro, July 31, GNA – Ghana is strengthening its health system to support the introduction of new HIV prevention technologies amid declining international funding and changing global healthcare priorities.
The National AIDS Control Programme (NACP) says the strategy will focus on integrating HIV services into primary healthcare while preparing the country to deploy emerging prevention medicines, including long-acting injectable therapies.
Dr Emmanuel Teviu, Programme Manager of the NACP, disclosed this in an interview with the Ghana News Agency on the sidelines of the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro, Brazil.
He said although long-acting HIV prevention medicines such as Lenacapavir represented a major scientific breakthrough, their impact would depend on the strength of national health systems.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in